by | Oct 2, 2025 | Lupus Foundation of America, News & Events
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the Definition of Remission in SLE (DORIS remission). Many people did not reach...
by | Sep 22, 2025 | Lupus Foundation of America, News & Events
AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that subcutaneous administration of the therapy demonstrated a statistically...
by | Sep 12, 2025 | Lupus Foundation of America, News & Events
A new study has found a significant association between Epstein-Barr Virus (EBV), a highly contagious virus primarily spread through saliva, and systemic lupus erythematosus (SLE), highlighting a possible link in the virus’ role in SLE pathogenesis. People who are...
by | Sep 12, 2025 | Lupus Foundation of America, News & Events
In a new study, right heart failure (RHF) hospitalizations of people with systemic lupus erythematosus (SLE) was associated with higher in-hospital mortality and non-fatal adverse outcomes. Lupus increases the risk for heart disease and cardiovascular morbidity....
by | Sep 11, 2025 | Lupus Foundation of America, News & Events
A cross-sectional study found that greater resilience, both on the individual and socio-ecological level, is linked to better mental health outcomes in individuals living with childhood-onset systemic lupus erythematosus (cSLE). Resilience is the ability to...
by | Sep 10, 2025 | Lupus Foundation of America, News & Events
A new study found veterans who have experienced pregnancy and are diagnosed with systemic lupus erythematosus (SLE) have an increased risk of experiencing adverse pregnancy and perinatal outcomes, including severe maternal morbidity (SMM). Veterans with SLE and...
